Mindful Body Awareness Training for MOUD - Baseline

Principal Investigator(s):  View help for Principal Investigator(s) Cynthia Price, University of Washington-Seattle

Version:  View help for Version V1

Name File Type Size Last Modified
mabt_oud_baseline_iscpr.dta application/x-stata-dta 117.4 KB 06/12/2024 03:30:PM

Project Citation: 

Price, Cynthia . Mindful Body Awareness Training for MOUD - Baseline. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2024-06-12. https://doi.org/10.3886/E205381V1

Project Description

Summary:  View help for Summary The national opioid epidemic requires development of real-world evidence-based treatments for opioid use disorder, including adjuncts to Medication for Opioid Use Disorder (MOUD). Interventions are needed that address the complex needs of patients with opioid use disorder, which include substantial mental health co-morbidity and high rates of chronic pain. This study tests a promising mind-body intervention, Mindful Awareness in Body-oriented Therapy (MABT), as an adjunct to MOUD across multiple community outpatient clinical settings. MABT, a novel mindfulness-based intervention, uniquely addresses aspects of awareness, interoception, and regulation that may be associated with pain, mental health distress, and behavioral control that increase risk of relapse and poor treatment outcomes. Using a randomized, two-group, repeated measures design, we will compare those who receive MABT+ MOUD to MOUD only. The specific aims are to evaluate the effectiveness of MABT + MOUD compared to MOUD only to: a) reduce opioid use and other illicit substances; 2) improve mental and physical health; and 3) improve interoceptive awareness and mindfulness skills.  A two-group (n = 165/165), randomized controlled repeated measures design will be employed. Assessments will be administered at baseline, post-intervention (3 months from baseline), and at 6, 9, and 12 months. Results of this study will inform the evidence base for behavioral treatment adjuncts to MOUD. This submission is the baseline data.

Scope of Project

Geographic Coverage:  View help for Geographic Coverage Pacific NW of the United States
Time Period(s):  View help for Time Period(s) 8/1/2019 – 1/1/2024 (Baseline)
Collection Date(s):  View help for Collection Date(s) 8/1/2019 – 1/1/2024
Universe:  View help for Universe Adult individuals in medication treatment for opioid use disorder.
Data Type(s):  View help for Data Type(s) survey data

Methodology

Response Rate:  View help for Response Rate 303 individuals enrolled in the clinical trial. 
Sampling:  View help for Sampling Individuals with opioid use disorder receiving medication for treatment were recruited to the study at six community clinics in the Pacific NW of the United States.  Eligibility criteria included being over 18 years of age, and stable on medication (at least 2 months of treatment). 
Collection Mode(s):  View help for Collection Mode(s) face-to-face interview; mixed mode; on-site questionnaire
Scales:  View help for Scales Timeline Followback interview 
GAD-7
PHQ-9
PCL-5
BPI
MAIA
DERS- Short Form
Frieberg Mindfulness Questionnaire (FMQ)
Weights:  View help for Weights Not applicable.
Unit(s) of Observation:  View help for Unit(s) of Observation Individual and study group.

Related Publications

Download this project

Published Versions

V1 [2024-06-12]

Export Metadata

Dublin Core

DDI 2.5

Report a Problem

Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.

This material is distributed exactly as received from the data depositor. As of April 2026, depositors are required to submit study materials in accessible formats. ICPSR has not reviewed, checked, or processed this material. For additional information about the study, please contact the investigator(s) directly. If you have questions about the accessibility of materials distributed by ICPSR or require further assistance, please visit ICPSR's Accessibility Center.